Brief: VolitionRx Says Cash, Cash Equivalents As Of Sep 30, 2022, Totaled About $16.4 Mln Compared With $16.7 Mln At Quarter Ended June 30, 2022
14/11/2022 21:50
Nov 14 (Reuters) - VolitionRX Ltd VNRX.A :
* VOLITIONRX LTD - CASH AND CASH EQUIVALENTS AS OF SEP 30,
2022,
TOTALED APPROXIMATELY $16.4 MILLION COMPARED WITH $16.7 MILLION
AT QUARTER ENDED JUNE 30, 2022
Source text for Eikon: ID:nPnc6gFRFa
Further company coverage: VNRX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VolitionRX
See all newsBrief: Volitionrx -Files Preliminary Prospectus For 10,006,360 Shares Of Common Stock Offered By Selling Stockholder - SEC Filing
Brief: Volitionrx - Advances Nu.Q Nets Platform Towards Commercialization
Brief: VolitionRX Limited Announces First Quarter 2026 Financial Results
Brief: Volition Reports Breakthrough In Liquid Biopsy Achievement Of Over 99% Purity In Isolating Cancer Dna
Brief: Volition Announces First Ever Automated Nu.Q® Vet Cancer Test With Fujifilm Vet Systems